Peter Brodersen is a Professor at the Department of Biology, University of Copenhagen , specializing in Bioinformatics and RNA Biology . His research focuses on RNA modification (m6A), YTHDF proteins, and small RNA pathways in plants. Recent research trends from his group include: (1) molecular mechanisms of ARGONAUTE-small RNA interactions, (2) m6A-YTHDF regulatory systems in plant development, and (3) RNAi-independent roles of DICER-LIKE proteins in antiviral defense. Collaborations span Denmark and international institutions. Publications highlight cross-disciplinary work bridging computational biology and experimental plant genetics. Key subfields include RNA structure, epigenetic regulation, and antiviral immunity.
Jeppe Bennekou Schroll serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based at Blegdamsvej 3, 2200 Copenhagen N, Denmark. His research expertise spans: Gynecology and Obstetrics Cervical Cancer Screening methodologies HPV Vaccination impact assessment Women's Urological Health Elderly Women's Gynecological Care Population-based Medical Research Dr. Schroll's 2025 publications demonstrate a concentrated focus on evidence-based gynecological interventions using Danish population data. His work bridges clinical practice and public health through cohort studies on HPV vaccination efficacy, surgical outcomes in elderly patients, and innovative non-surgical treatments for urinary incontinence. The research consistently employs robust methodologies including population registries and randomized controlled trials, with significant media coverage across 14 news outlets and social platforms.
Professor John W. Edmunds is a leading academic in Infectious Disease Modelling at the London School of Hygiene and Tropical Medicine (LSHTM). Holding a Professor position since 2013 and serving as Dean of the Faculty of Epidemiology and Population Health (2013-2019), he combines mathematical, statistical, and economic models to inform public health policy. His part-time role at the Health Protection Agency (HPA) since 2008 underscores his policy advisory contributions. PhD in Infectious Disease Modelling (Imperial College, 1994) MSc in Health Economics (University of York, 1995) BSc in Biology (Imperial College, 1989) His research focuses on understanding disease transmission and optimizing control strategies. He has pioneered methods integrating social contact surveys , participatory surveillance (e.g., Influenzanet), and economic analysis to evaluate vaccines and interventions. Recent work includes SARS-CoV-2 dynamics , Ebola spatial forecasting , and typhoid vaccine prioritization . His 15 most recent publications highlight social contact patterns (Reconnect, CoMix studies), vaccine impact (HPV, typhoid), and real-time outbreak analytics (Ebola, cholera). Key trends include digital epidemiology , behavioral surveillance , and cross-country modeling for global health. Knighthood (2024) for services to epidemiology Weldon Memorial Prize (2022) for biostatistics contributions FMedSci (2018) for medical science excellence OBE (2016) for public service As an educator, he teaches "Modelling and the Dynamics of Infectious Diseases" and co-organizes "Pandemics: Emergence, Spread and Response" . Current grants include National Institute for Health and Care Research projects on post-pandemic surveillance and Bill & Melinda Gates Foundation funding for polio eradication. He leads collaborations with the Centre for Mathematical Modelling of Infectious Diseases , Vaccine Centre , and Health in Humanitarian Crises Centre , while advising UK and WHO committees on zoonotic influenza , variants , and testing programs .
Konstantinos Kalogeropoulos is an Assistant Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), leading research at the Cell Diversity Lab. His work bridges proteomics, computational biology, and snake venom research. Current projects: "The Proteomic Landscape during Influenza Infection" (2022-2025) Supervisor for PhD projects on protease network rewiring in psoriasis and wound exudate degradomics Research interests include: Proteomic analysis of inflammatory diseases Snake venom toxin structure prediction Extracellular matrix biomechanics De novo peptide sequencing algorithms Computational modeling of protease networks Recent article trends demonstrate his work in • Database-free proteomics (InstaNovo/InstaNexus) • Snake venom pathophysiology (V-ToCs clustering) • Inflammatory disease biomarkers (psoriasis, impaired healing) • Extracellular matrix mechanics (fibronectin tension, gut inflammation) Advising: Supervises PhD students Polhaus, C. J. M. and Haack, A. M., focusing on protease networks and wound healing.
Mads Albertsen is a Professor in the Department of Chemistry and Life Sciences at the Faculty of Engineering and Science, Aalborg University, Denmark. He leads the Albertsen Lab and is a key member of the Center for Microbial Communities. His research focuses on high-throughput DNA sequencing methods to explore uncultivated microbes and populate the tree of life. He is actively involved in major interdisciplinary projects such as NanoEat , Microflora Danica , and DarkScience , funded by the European Research Council, Villum Foundation, and Poul Due Jensen Foundation. His research interests span metagenomics , long-read sequencing , bioinformatics , microbial ecology , and environmental biotechnology . He develops cutting-edge methods to improve throughput in microbial genome recovery and applies them to diverse areas including wastewater treatment, human microbiome studies, and infectious disease diagnostics. His work has significant implications for public health and sustainability. The recent publications highlight a strong trend in long-read sequencing (Oxford Nanopore), metagenome-assembled genomes (MAGs) , and microbial dark matter . His team has published high-impact papers in Nature , Nature Methods , and Nature Communications , with applications in environmental systems and clinical diagnostics, including SARS-CoV-2 and bloodstream infections. His scientific awards include: The Grundfos Prize (2021) The Fritz Kaufmann Prize (2021) The Rising Star Award by IWA & ISME (2016) Research Result of the Year in Denmark (2015) The Spar Nord Fond Research Prize (2015) Mads Albertsen advises numerous PhD students, leads externally funded research projects, and is involved in technology transfer through his co-founding of DNASense ApS (2014–2020). He also serves on scientific advisory boards and contributes to public policy, including as a member of the Danish SARS-CoV-2 variant risk-assessment group. He teaches courses in Data Science, Bioinformatics, Genomics, and Environmental Microbiology at Aalborg University. His lab, the Albertsen Lab , is part of the Center for Microbial Communities , a leading research center focused on microbial systems biology and environmental applications. The lab collaborates extensively with national and international partners in academia, industry, and public health institutions.
Hans H. Wandall is Professor and Deputy Head of Department at the University of Copenhagen's Department of Cellular and Molecular Medicine, Faculty of Health Sciences. He serves as Group Leader and Vice-Director of the Copenhagen Center for Glycomics. His educational background includes a PhD in Glycobiology (2004), medical licensure (2001), and MD from University of Copenhagen (1999). Research focuses on glycobiology using gene editing and tissue models to understand glycan functions in: Tissue development and cancer biology Host-virus interactions (HSV-1, Ebola) Stem cell regulation and regenerative medicine Glycan-based therapeutic development Recent publications demonstrate interdisciplinary approaches combining glycoproteomics, virology, and cancer biology, with emphasis on O-glycosylation mechanisms and viral pathogenesis. Awards & Recognition: ERC Consolidator Grant (2017) Lundbeck Foundation Ascending Investigator (2019) Sapere Aude Research Leader Award (2012) Young Scientist Award (2003) Leads multiple funded projects from Lundbeck Foundation, Novo Nordisk Foundation, and Danish National Research Foundation. Supervises doctoral candidates and postdoctoral researchers while directing the GlycoMedicine research group. Founded biotech ventures including GO-Therapeutics and Hemab ApS.
Mette Hedegaard Thomsen is a Professor at the Department of Chemistry and Bioscience, Aalborg University. Her research focuses on biorefinery systems, halophyte utilization, and microbiologically influenced corrosion (MIC) mitigation. She leads projects involving valorization of organic waste, development of natural biocides, and sustainable biofuel production. Research Interests: Halophyte-based biorefineries Microbial corrosion inhibition Organic waste-to-energy conversion Phenolic compound extraction Probiotic/postbiotic applications Key Projects (2018–2027): Biorefinery of Biomass Residues for High-Value Compounds Improving GreeN Innovation for Sustainable Animal Farming Halophyte Extracts as Natural Corrosion Inhibitors Advising & Grants: Supervisor for 4 PhD students Funded by EU Horizon 2022 and industry partnerships Labs/Teams: Halophyte Biorefinery Lab Corrosion Inhibition Research Group Waste Valorization Consortium
Anne Zebitz Eriksen is an Assistant Professor at the Department of Health Technology, Technical University of Denmark (DTU), specializing in Cell and Drug Technologies within Tailored Materials and Tissues. Her research integrates pharmaceutical science, biomedical engineering, and ophthalmology to develop advanced drug delivery systems and nanocarriers. University: Technical University of Denmark Department: Health Technology Academic Rank: Assistant Professor Research Interests: Her work focuses on liposome engineering, membrane translocation mechanisms, ocular drug delivery, and 3D stem cell-derived organoids. She actively contributes to addressing challenges in diabetic retinopathy, viral infections (e.g., SARS-CoV-2), and intestinal bioavailability. Article Trends: Recent publications highlight her expertise in lipid-based nanocarriers, ocular pharmacokinetics, and organoid models. Key themes include peptide transport optimization, antiviral protocols, and bioprinting perfusable vasculatures for tissue engineering. Supervision & Collaboration: She supervises PhD projects on microsystems for tissue actuation and bioprinted vasculatures, collaborating with institutions like DTU Health Tech. Her research aligns with UN SDGs for health and well-being, emphasizing innovative drug delivery solutions.
Axel Skytthe is a researcher at the University of Southern Denmark with a focus on Epidemiology, Biostatistics and Biodemography (EBB) . His research spans medical demography , genetic epidemiology , twin studies , and aging . He is affiliated with the Danish Center for Twin Research and the Institute for Health Services Research . Research Interests : Axel’s work primarily investigates genetic and environmental influences on aging, disease susceptibility, and mortality through large-scale twin cohorts. His studies often intersect with genetics , biostatistics , and demographic trends . Recent projects include analyzing BMI development across early life stages and exploring mTOR pathway epigenetics in tic disorders. Publications : His extensive body of work (203 publications) includes groundbreaking twin studies on respiratory syncytial virus , tic comorbidities , and exceptional lifespans . Collaborative research spans 25 twin cohorts globally, highlighting genetic determinism and environmental interactions. Professional Activities : Axel has participated in major conferences like the 15th International Society for Twin Studies Congress (2014) and European Congress of Epidemiology (2013). He is also a peer reviewer and board member in several organizations.
Bitten Aagaard Jensen serves as a Leading Senior Physician (Ledende overlæge) at Aalborg University Hospital within The Faculty of Medicine's Department of Clinical Immunology. She maintains an active research profile with 48 publications documented through 2025 and has contributed to 6 significant datasets, particularly related to SARS-CoV-2 antibody research. Her research interests span Clinical Immunology, Blood Donation Research, Infectious Diseases, and Inflammatory Diseases. She has been particularly active in studying blood donor health, SARS-CoV-2 seroprevalence in vulnerable populations, and genetic associations with immunological conditions. Her work often involves large-scale epidemiological studies with thousands of participants. Dr. Jensen's publication record shows consistent productivity, with 17 publications in 2025 alone (as of the data collection), 10 in 2024, 4 in 2023, and 8 in 2022. Her research frequently appears in high-impact journals including Journal of Allergy and Clinical Immunology, Scientific Reports, European Journal of Epidemiology, Clinical Microbiology and Infection, and BMJ Open Gastroenterology. Extensive work on SARS-CoV-2 antibody prevalence in vulnerable populations including social housing residents and homeless individuals Research on blood donor health parameters and safety Genetic studies related to inflammatory conditions Investigations into infectious disease markers and immune responses Her media presence includes coverage in 6 news outlets regarding blood donor coronavirus testing in 2020, demonstrating her engagement with public health communication. She collaborates extensively with researchers across Denmark, particularly with colleagues at blood banks, university hospitals, and epidemiological research centers.
Professor Peter Højrup is affiliated with the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, focusing on protein structure and function through advanced biochemical techniques such as mass spectrometry and chemical cross-linking. His research spans biomedical mass spectrometry, systems biology, and proteomics, with a particular emphasis on endoplasmic reticulum proteins like calreticulin and calnexin. Education: PhD in Molecular Biology (1986, Odense University), MSc in Molecular Biology (major) and Chemistry (minor) (1982, University of Aarhus) His research interests include: Developing methods for determining protein 3D structures and interactions via chemical cross-linking and mass spectrometry. Fast glycosylation analysis of immunoglobulins and cancer markers. De novo proteomics of fish mucus proteins. The articles highlight trends in mass spectrometry applications, structural biology, and glycosylation studies, with recent work on SARS-CoV-2 epitope mapping, therapeutic antibody characterization, and host cell protein quantitation. Supervision includes training postdocs, PhD, MSc, and BSc students, though specific student names are not provided.
Svend Birkelund is a Professor and Head of Research Group in the Department of Health Science and Technology at Aalborg University, Faculty of Medicine. His academic work is centered on medical microbiology and immunology, with a strong emphasis on molecular bacterial pathogenesis. Doctor of Medical Science (DMSc), Aarhus University, 1992 PhD, University of Aarhus, 1989 MD, University of Copenhagen, 1983 His research focuses on how pathogenic bacteria such as Chlamydia trachomatis and Klebsiella pneumoniae interact with the human immune system, particularly the complement system and innate immune responses. His recent work explores serum resistance mechanisms, leukocyte migration via aquaporins, and biomarker discovery in inflammatory joint diseases. He contributes to UN Sustainable Development Goals related to health and well-being. Analysis of his recent publications reveals a strong trend in immunology and microbiology, with increasing use of proteomics and systems biology approaches. His work spans fundamental host-pathogen interactions, clinical immunology, and translational applications in diagnostics and therapy. He has contributed to significant research projects, including: Elimination of microorganisms by the innate immune system (Obel Family Foundation) Biomarkers in Osteoarthritis Interleukin-1 in inflammatory diseases Analysis of citrullinated peptides in autoimmune triggers His datasets on proteomic analysis of synovial fluid and complement deposition on Chlamydia are publicly available. He has supervised multiple PhD students and is frequently engaged in public discourse on antibiotic-resistant bacteria through media appearances. He is actively involved in interdisciplinary collaborations and leads a research group focused on advancing understanding of infectious and inflammatory diseases through molecular and immunological approaches.
Pawel Wargocki is a Professor at the Department of Environmental and Resource Engineering, Technical University of Denmark (DTU). His research focuses on indoor environmental quality, air quality management, and human health impacts of building systems. He leads projects addressing airborne infection risk, thermal comfort, and ventilation strategies in schools, offices, and healthcare settings. Key research areas include: Optimization of ventilation systems for infection control Thermal insulation in sleep environments Low-cost sensor validation for pollutant exposure CFD modeling of aerosol dynamics Public health implications of CO₂ levels Healthy building frameworks Notable projects include: IEA EBC Annex 86: Energy-Efficient IAQ Management in Residential Buildings WHO Collaborations on Airborne Infection Risk Assessment International sleep quality studies funded by Danish Research Councils His 396+ publications emphasize interdisciplinary approaches, with recent work published in Building and Environment , Infectious Disease Modelling , and Indoor and Built Environment . He supervises PhD students exploring cognitive performance in classrooms and HVAC energy savings.
Hau Van Nguyen is a Researcher in the Drug Delivery and Sensing group under the Department of Health Technology at the Technical University of Denmark . His work focuses on developing microfluidic platforms for biomedical applications, particularly studying virus infections and periodontitis. Research Areas : Microfluidics, virology, periodontitis, in vitro models, and lab-on-a-chip technology. Publications : Recent studies include centrifugal microfluidic platforms for HSV-1 infection research and dynamic in vitro models for periodontitis. Activities : Active in conference presentations discussing microfluidic cell culture systems and their applications in infectious disease research.
Pedro Póvoa is an Adjunct Professor at the Department of Clinical Research, University of Southern Denmark (KI, OUH, Research Unit of Clinical Epidemiology, Odense). His work focuses on Critical Care Medicine, Infectious Diseases, and Respiratory Infections. Research Interests His research spans topics such as ventilator-associated pneumonia, immunosuppression effects on infections, nosocomial disease mortality, and pandemic response strategies like the coVAPid Study Group. Key areas include Clinical Epidemiology , Artificial Respiration , and Antibiotic Use in ICU settings. Recent Publications His recent studies (2025) address ventilator-associated pneumonia definitions (RECUVAP), immunosuppression impacts on respiratory infections (MIMOSA), and pneumonia treatment protocols. These align with Cohort Analysis , Multicenter Studies , and Delphi Method applications. Collaborations Póvoa collaborates with the European Network for ICU-Related Respiratory Infections (ENIRRIs) and coVAPid Study Group, reflecting his commitment to global critical care research and pandemic resilience.
